STAMFORD, Conn., July 22, 2020 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing […]
Second Quarter Financial Highlights*Record revenues of $184.8 million, up 47%Record operating income of $104.1 million, up 71%Record operating margin of […]
Company’s advanced sensor platform provides market-leading imaging and non-imaging technology solutions with high performance, reliability and accuracy MIGDAL HAEMEK, [...]